STEPHANIE BOHANNON: Open Payments
NPI 1104459114 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,295 in 124 payments from 13 companies in 2025. Trend: 2023 $1,667 · 2024 $11,091 · 2025 $16,295
Honoraria: $11,250Food & beverage: $2,699Speaker / faculty: $1,500Travel & lodging: $845
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 26 | $12,947 |
| ABBVIE INC. | 20 | $1,888 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $400 |
| Vanda Pharmaceuticals Inc. | 13 | $349 |
| Neurocrine BioSciences, Inc. | 9 | $200 |
| Supernus Pharmaceuticals, Inc. | 1 | $119 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 |
| Corium, LLC | 8 | $88 |
| Lundbeck LLC | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
Products named: Auvelity, VRAYLAR, CAPLYTA, FANAPT, INGREZZA, REXULTI, Qelbree, AUSTEDO XR.
Industry payments across AR — which companies pay providers there.
